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Abstract
Objective To determine whether supplementation with vitamin D
improves resilience to the adverse effects of earthquakes.
Design Opportunistic addition to an established randomised double
blind placebo controlled trial.
Setting Christchurch, New Zealand, where a prolonged series of
catastrophic earthquakes beginning on 4 September 2010 occurred,
which caused widespread destruction, fatalities, and extensive
psychological damage.
Participants 322 healthy adults (241 women; 81 men) aged 18-67 who
were already participating in the vitamin D and acute respiratory
infections study (VIDARIS) between February 2010 and November 2011.
Intervention Participants were randomised to receive an oral dose of
either 200 000 IU vitamin D3 monthly for two months then 100 000 IU
monthly (n=161) or placebo (n=161) for a total of 18 months.
Main outcome measure This is a post hoc analysis from the previously
published VIDARIS trial. The primary endpoint in the current analysis
was the self reported effects and overall adverse impact of the
Christchurch earthquakes as assessed by questionnaire four months
after the most destructive earthquake on 22 February 2011, which was
used as the index event. The secondary end point was the number of
“psychological” adverse events that participants reported at their usual
monthly appointments as part of the original VIDARIS trial.
Results 308 participants completed the earthquake impact questionnaire
(n=152 in the vitamin D group and 156 in the placebo group). There was
no significant difference in the number of self reported adverse effects
between those receiving vitamin D supplementation and those receiving
placebo. There was also no difference in the overall adverse impact
score between treatment groups (χ
2 P=0.44). The exception was that
those in the vitamin D group experienced more adverse effects on family
relationships (22% v 13%; χ
2 P=0.03). The number of psychological
adverse events—such as fatigue, stress, anxiety, and insomnia—that
participants reported at their usual monthly appointments was significantly
higher after the earthquake (χ
2 P=0.007) but did not differ between
treatment groups.
Conclusion In this trial, vitamin D supplementation did not reduce the
adverse impact of earthquakes in healthy adults.
Trial registration Australian New Zealand Clinical Trials Registry (anzctr.
org.au) ACTRN12609000486224
Introduction
VitaminDisviewedinsomecirclesassomethingofapanacea,
and, currently, no other vitamin receives more attention in the
scientific literature.
1 2 One topic of interest is the potential
relation between vitamin D status and mental health.
Epidemiologicalstudiessuggestanassociationbetweenvitamin
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Research
RESEARCHD status and mental wellbeing, particularly depression and
anxiety.
3-6 This is plausible because the requisite hydroxylases
and vitamin D receptors for the local production and use of the
biologically active 1,25-dihydroxyvitamin D have been found
in important behavioural and emotional regions of the brain.
4 7
Evidence also suggests that vitamin D is involved in the
biosynthesisofneurotransmittersandcouldhaveneuroprotective
and psychotropic effects.
8-10
Experiencinganaturaldisastersuchasadestructiveearthquake
adversely affects mental health. Several studies have reported
heightened anxiety, depression, and an increased incidence of
post-traumatic stress disorder
11-13 in earthquake survivors, and
these effects can last for several years.
11-15
Arandomisedcontrolledtrialinhealthyadultsthatinvestigated
the effect of monthly high dose vitamin D supplementation on
upper respiratory tract infections (VIDARIS
16) was undertaken
inChristchurch,NewZealandfromFebruary2010toNovember
2011. During this time, the region experienced a series of
catastrophic earthquakes. These began on 4 September 2010 at
4 35 am, when a magnitude 7.1 earthquake struck. A series of
aftershocks followed, with the most devastating being a 6.3
magnitude earthquake on 22 February 2011 at 12 51 pm,
resultingin185deaths,thelossofmorethan60%ofthecentral
business district, and severe damage to housing and
infrastructure.
17
This chance occurrence provided a novel opportunity to assess
in the VIDARIS participants whether vitamin D3
supplementation had any effect on the adverse impact
experienced during a prolonged series of devastating
earthquakes.
Methods
Study design, participants, and randomisation
The VIDARIS trial was conducted in healthy adults in
Christchurch, New Zealand, between February 2010 and
November 2011 and has been described in detail elsewhere.
16
Briefly, participants were staff or students aged ≥18 from the
Canterbury District Health Board or the University of Otago,
Christchurch. Volunteers were screened for eligibility and
enrolled during February through April 2010.
Interviewers administered questionnaire to determine the
baseline characteristics. Both participants and study personnel
conducting the trial were blinded to treatment allocation.
Participants randomised to vitamin D3 received orally
supplementation of 200 000 IU at study initiation, another 200
000IUonemonthlater,andthen100000IUmonthlythereafter
for18months.Thoserandomisedtoplaceboreceivedmatching
inactive tablets given in an identical dosing regimen. The
vitamin D3 and placebo tablets were obtained from Tishcon
(Westbury, NY).
The earthquakes
The magnitude 7.1 earthquake on 4 September was centred 38
km west of Christchurch City at a depth of 11 km. Although
this initial earthquake was strong, shallow, and close to a city,
there were no fatalities and little injury. There was, however,
large scale damage to buildings and infrastructure (water,
sewerage, electricity, and roads) throughout the city. Over the
following 15 months (September 2010 to November 2011) the
region experienced 10 741 aftershocks within a 100 km radius
ofthecityofChristchurch.Ofthese,over3400weremagnitude
≥3and<20kmdeepandwerereadilyfeltbymostpeople(www.
canterburyquakelive.co.nz (C Crowe) and www.geonet.co.nz;
fig 1⇓).
Procedures
Dedicated research staff met participants in person each month
over the 18 months to administer the dose of study treatment
and to conduct a brief interview. For each participant, as part
of the usual monthly questionnaire, researchers recorded any
unplanned visits to a doctor/after hours clinic/hospital or any
new health problem or change in the frequency/severity of an
existing health problem as a new adverse event.
Separately, participants were asked a specific questionnaire
about the impact of the earthquakes at their first appointment
four months after the 22 February 2011 aftershock, which was
usedastheindexeventbecauseitwasthemostdestructive.The
questionnaire included 14 questions, which covered damage to
homes,thedeathofafamilymember/closefriend,andpersonal
impact. In addition, participants conveyed the overall adverse
impact by answering the question: “on a scale of 1-7, with 1
being no impact at all and 7 being high impact; overall what
adverse impact has the earthquake on the 22 February had on
you? (circle one)” (see appendix).
Analysis
We performed Pearson’s χ
2 tests on an intention to treat basis
to determine any difference between the treatment arms in the
number of self reported adverse effects and overall adverse
impact score as assessed through the earthquake questionnaire
and the number of adverse events reported at monthly
appointments.Allstatisticaltestsweretwosidedandconsidered
significant at P<0.05. The software used was SPSS, version 22
(IBM).
Results
Intotal,322participants(241women)wererandomisedtostudy
treatment. Table 1 shows their baseline characteristics⇓. The
earthquake questionnaire was completed by 308 participants at
their usual monthly appointment four months after the index
event of the 22 February 2011, including 15 (5%) participants
who had previously withdrawn from treatment (fig 2⇓). The
groups were balanced in terms of reported levels of personal
loss, injury, and damage to property as a result of the
earthquakes. Mental wellbeing outcomes, such as disturbed
sleep, increased anxiety/stress, and diminished concentration,
were not significantly different between the groups (table 2⇓).
TheonlyexceptionwasthatthosereceivingvitaminDreported
a higher level of experiencing an adverse effect on family
relationships(22%v13%;χ
2P=0.03).Therewasalsonorelation
between study arm and the distribution of the overall impact
score.
Figure3showsthetotalnumberofadverseeventsreportedeach
month during the trial⇓ (n=1282). The reported number of
“psychological”adverseevents,suchasstress,anxiety,fatigue,
or depression, did not differ between treatment arms but were
significantly higher after the 22 February 2011 earthquake
(n=64) compared with the number reported before the
earthquake (n=37; χ
2 P=0.007).
Discussion
Our earthquake questionnaire provided a snapshot of the self
reported adverse effects and broad impact of the Canterbury
earthquakes in a cohort of healthy adults who were
coincidentally taking part in a randomised controlled trial of
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RESEARCHvitamin D3 supplementation (VIDARIS).
16 We found no
significant association between the receipt of monthly vitamin
D supplements and the overall adverse impact score or most
specific effects of earthquakes. Those receiving vitamin D
reported a higher level of experiencing an adverse effect on
family relationships. Although this finding was significant at
P<0.05, in the context of a lack of effect of vitamin D on the
other stress related outcomes, which might be expected to
underpin family relationship stress, it would not be appropriate
to conclude that vitamin D increases the likelihood of adverse
effects on family relationships.
Strengths and limitations
The strengths of our study include the randomised
supplementation and the high retention and response rate to the
earthquake questionnaire. An important limitation was that we
didnotassessmentalwellbeingusingavalidatedquestionnaire,
such as the depression, anxiety, and stress scale. As such we
cannot be sure we have captured the true extent of the
psychological impact of the earthquakes. It was clear from our
monthlycontactwithparticipants,however,thatalargenumber
were experiencing increased anxiety/stress, and, while we
wanted to capture the impact of the earthquakes, we did not
want to overburden participants with a lengthy questionnaire.
Asurveyofthedisasterliteratureallowedustogenerateashort
questionnaire that would provide an indication of the physical
and mental impact of the earthquakes.
The questionnaire was not completed until four months after
the index event. While participants could have “forgotten” or
potentiallyminimisedtheimpactofthemajorearthquake,there
were continual aftershocks throughout this period, including a
6.3 magnitude tremor just before the start of the survey. A
further limitation is that while this study was appropriately
powered for the VIDARIS outcomes, for some categories of
the overall adverse impact score the numbers are small.
Possible explanatory links
The adverse psychological impact of earthquakes is well
documented,
12-14includingseveralstudiesinvestigatingtheeffect
of the Canterbury earthquakes.
11-21 Given that there are
epidemiological data supporting a possible role for vitamin D
in the improvement of mental wellbeing,
3-6 it was plausible that
vitamin D supplementation could potentially reduce anxiety or
stress or the overall adverse impact of the earthquakes. Of the
fewrandomisedcontrolledtrialsthathaveinvestigatedtheeffect
of vitamin D supplementation on mental wellbeing, however,
the findings have been mixed.
22-26 No improvement in mental
wellbeing was observed when older women were given an
annual high dose of vitamin D
26 nor was there any effect on
depressive scores in participants with low vitamin D
concentrations who received vitamin D supplements.
25 In
contrast,astudywithobeseparticipantsfoundanimprovement
indepressivescoresaftersupplementation.
24Nootherdatahave
been reported from randomised controlled trials regarding the
roleofvitaminDinreducingtheadverseeffectsofearthquakes.
One of the most remarkable aspects was the overall resilience
and dedication of the participants and research team to see the
study through, regardless of the personal losses, damage to
property, and constant general chaos. Only two participants
cited the earthquakes as the direct reason for their withdrawal,
and294(91%)completedthestudyontreatment.Wealsolearnt
some lessons that could be applicable to future studies because
a natural disaster can strike at any time. For example, having a
back-up supply of a small amount of study treatment at an
alternativesiteisimportantifaccesstothestudysiteissuddenly
compromised. Similarly, ensuring that data are entered into
electronic databases in real time and having offsite access to
the data and all study forms/questionnaires allows the study to
continue or restart quickly.
In conclusion, despite the fashion for vitamin D
supplementation, this study suggests that it does not reduce the
adverse impact of earthquakes.
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RESEARCHTables
Table 1| Characteristics of participants affected by earthquakes in New Zealand in by treatment arm
Placebo (n=161) Vitamin D (n=161) Characteristic
48 (10) 47 (10) Mean (SD) age (years)
28 (5) 27 (5) Mean (SD) BMI
120 (75) 121 (75) No (%) of women
8 (5) 7 (4) No (%) with Māori/Pacific ethnicity*
71 (22) 73 (22) Mean (SD) baseline serum 25-OHD (nmol/L)
BMI=body mass index; 25OHD=25-hydroxyvitamin D3 (calcidiol).
*Self identified as Māori/Pacific ethnicity, which includes Samoan, Cook Islands, Māori, Tongan, Niuean, Fijian, Tokelauan, Tuvaluan.
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RESEARCHTable 2| Self reported impact of earthquakes by treatment arm (n=308). Figures are numbers (percentage) of participants
χ
2 (P value) Placebo (n=156) Vitamin D (n=152)
3.25 (0.07) 151 (97) 140 (92) Felt earthquake 22 February 2011
Physical injury:
2.71 (0.10) 24 (15) 14 (9) Close family member or friend died
1.62 (0.20) 10 (6) 5 (3) Personal injury
0.08 (0.77) 10 (6) 11 (7) Close family member or friend injured
Property damage:
1.41 (0.24) 101 (65) 108 (71) House
1.41 (0.24) 101 (65) 108 (71) Electricity supply
0.43 (0.51) 96 (62) 99 (65) Water supply
2.92 (0.09) 70 (45) 83 (55) Sewerage/waste water
0.07 (0.79) 90 (58) 90 (59) Disruption to employment/business
1.42 (0.23) 21 (14) 28 (18) Adverse changes to financial situation
Psychological impact:
3.33 (0.07) 109 (70) 120 (79) Disrupted sleeping patterns
<0.001 (0.99) 121 (78) 118 (78) Increased anxiety/stress (tense, hypervigilant, easily startled, irritable)
0.58 (0.45) 93 (60) 97 (64) Diminished ability to concentrate on tasks
0.11 (0.74) 72 (46) 73 (48) Diminished interest in participating in activities
4.85 (0.03) 20 (13) 34 (22) Adverse effect on family relationships
Overall adverse impact score:
5.88 (0.44) 4 (3) 6 (4) 1 (low)
27 (17) 20 (13) 2
38 (24) 34 (22) 3
34 (22) 24 (16) 4
32 (21) 46 (30) 5
16 (10) 17 (11) 6
5 (3) 5 (3) 7 (high)
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RESEARCHFigures
Fig 1 Earthquakes and aftershocks during course of trial. Magnitude on Richter scale is base 10 logarithmic scale, therefore
6 on scale is 10 times magnitude of 5
Fig 2 Flow of participants in study on effect of vitamin D3 supplementation on adverse effects of earthquakes
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RESEARCHFig 3 Number of adverse events reported at monthly appointments per 100 people by treatment arm. Fatigue and
“psychological” adverse events included anxiety, stress, and depression
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RESEARCH